Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 446 | 3,290 | 3,223 | 1,444 | 1,845 |
| Marketable Securities | 3,915 | 4,181 | 4,153 | 8,332 | 9,800 |
| Receivables | 642 | 1,081 | 1,497 | 1,273 | 226 |
| Inventories | 345 | 205 | 238 | 461 | N/A |
| TOTAL | $5,948 | $9,348 | $9,741 | $12,362 | $12,653 |
| Non-Current Assets | |||||
| PPE Net | 941 | 968 | 798 | 742 | 763 |
| Intangibles | 4,993 | 5,097 | 5,203 | 5,308 | 5,417 |
| Other Non-Current Assets | 1,147 | 927 | 1,001 | 1,075 | 1,198 |
| TOTAL | $7,081 | $6,992 | $7,002 | $7,125 | $7,378 |
| Total Assets | $13,029 | $16,340 | $16,743 | $19,487 | $20,031 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 789 | N/A |
| Accounts payable and accrued liabilities | 1,209 | 1,553 | 2,484 | 2,469 | 1,655 |
| Accrued Expenses | 51 | 832 | 571 | 311 | 49 |
| TOTAL | $2,542 | $3,670 | $4,592 | $4,768 | $2,996 |
| Non-Current Liabilities | |||||
| Long Term Debt | 264 | 294 | 324 | 354 | 383 |
| Deferred Revenues | 988 | 992 | 996 | 1,199 | 476 |
| Other Non-Current Liabilities | 13,731 | 13,715 | 13,703 | 13,876 | 13,833 |
| TOTAL | $13,995 | $14,009 | $14,027 | $14,230 | $14,216 |
| Total Liabilities | $16,537 | $17,679 | $18,619 | $18,998 | $17,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 2 | 2 | 2 |
| Common Shares | 133 | 133 | 132 | 132 | 132 |
| Retained earnings | -51,593 | -49,387 | -49,703 | -47,292 | -44,940 |
| Other shareholders' equity | -1,395 | -1,402 | -1,434 | -1,340 | -1,365 |
| TOTAL | $-3,508 | $-1,339 | $-1,876 | $489 | $2,819 |
| Total Liabilities And Equity | $13,029 | $16,340 | $16,743 | $19,487 | $20,031 |